EP3166939
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
7.7.2015:
5.6.2019:
15744417.5
:
6.7.2035
:
THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF
7.7.2015
5.6.2019
:
Genentech, Inc.:
1 DNA Way, 94080-4990, South San Francisco, CA, US
:
Xenon Pharmaceuticals Inc.:
200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, CA
:
ANDREZ, Jean-Christophe:
BurnabyBritish Columbia V5G 4W8, CA
:
BERGERON, Philippe:
South San Francisco, CA, US
:
BICHLER, Paul Robert:
BurnabyBritish Columbia V5G 4W8, CA
:
CHOWDHURY, Sultan:
BurnabyBritish Columbia V5G 4W8, CA
:
DEHNHARDT, Christoph Martin:
BurnabyBritish Columbia V5G 4W8, CA
:
FOCKEN, Thilo:
BurnabyBritish Columbia V5G 4W8, CA
:
GONG, Wei:
BurnabyBritish Columbia V5G 4W8, CA
:
GRIMWOOD, Michael Edward:
BurnabyBritish Columbia V5G 4W8, CA
:
HASAN, Abid:
BurnabyBritish Columbia V5G 4W8, CA
:
HEMEON, Ivan William:
BurnabyBritish Columbia V5G 4W8, CA
:
JIA, Qi:
BurnabyBritish Columbia V5G 4W8, CA
:
SAFINA, Brian:
South San Francisco, CA, US
:
SUN, Shaoyi:
BurnabyBritish Columbia V5G 4W8, CA
:
WILSON, Michael Scott:
BurnabyBritish Columbia V5G 4W8, CA
:
ZENOVA, Alla Yurevna:
BurnabyBritish Columbia V5G 4W8, CA
:
201462021587 P:
7.7.2014:
US
:
US2015039413:
7.7.2015
:
C07D 403/12, C07D 413/14, C07D 221/22, C07D 401/10, C07D 401/12, C07D 403/10, C07D 413/12, C07C 235/52, C07D 205/04, C07D 207/16, C07D 277/06, C07D 209/02, C07D 305/08, A61K 31/401, A61P 17/04